Notice2022-04259
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-CK-22-006, Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases; Cancellation of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 1, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 40 (Tuesday, March 1, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Page 11448]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-04259]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--RFA-CK-22-006, Clinical and Applied Research
Strategies for the Prevention and Control of Fungal Diseases;
Cancellation of Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the
meeting of the Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP)--RFA-CK-22-006, Clinical and Applied
Research Strategies for the Prevention and Control of Fungal Diseases;
April 14, 2022, 10:00 a.m.-5:00 p.m., EDT. The teleconference was
published in the Federal Register on February 14, 2022, Volume 87,
Number 30, page 8251.
This meeting is being canceled in its entirety.
FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, National Center for HIV, Viral
Hepatitis, STD, and TB Prevention, 1600 Clifton Road NE, Mailstop US8-
1, Atlanta, Georgia 30329, (404) 718-8833, <a href="/cdn-cgi/l/email-protection#a5c2c4cbc1c0d7d6cacbe5c6c1c68bc2cad3"><span class="__cf_email__" data-cfemail="3a5d5b545e5f484955547a595e59145d554c">[email protected]</span></a>.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-04259 Filed 2-28-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 1, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.